Track topics on Twitter Track topics that are important to you
A study comparing the safety and efficacy of SAR342434, a biosimilar (follow-on form) of insulin lispro-Humalog, found it to be comparable to that of the brand name drug in patients also using insulin glargine. The phase 3, randomized SORELLA 1 trial evaluated changes in HbA1c, fasting plasma glucose, and self-monitored plasma glucose levels, as well as hypoglycemic events, and the results are published in Diabetes Technology & Therapeutics.NEXT ARTICLE
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...